Faculty Information - FURUTANI Yoshiyuki

（Last updated : 2022-11-30 14:24:36）

FURUTANI Yoshiyuki
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Department of Surgery, Division of Pediatric Cardiology and Adult Congenital Cardiology

Position

■ Published papers

1.	Original article	Functional Evaluation of Human Bioengineered Cardiac Tissue Using iPS Cells Derived from a Patient with Lamin Variant Dilated Cardiomyopathy. 2022/03/30
2.	Original article	Incidence and Expected Probability of Liver Cirrhosis and Hepatocellular Carcinoma After Fontan Operation. 2021/12
3.	Original article	Silibinin Upregulates CXCR4 Expression in Cultured Bone Marrow Cells (BMCs) Especially in Pulmonary Arterial Hypertension Rat Model. 2020/05
4.	Original article	Noonan syndrome-associated biallelic LZTR1 mutations cause cardiac hypertrophy and vascular malformations in zebrafish. 2020/03
5.	Original article	Silibinin efficacy in a rat model of pulmonary arterial hypertension using monocrotaline and chronic hypoxia. 2019/04
6.	Original article	Role of BRCA1-associated protein (BRAP) variant in childhood pulmonary arterial hypertension. 2019/01
7.	Original article	Prognostic predictive value of gene mutations in Japanese patients with hypertrophic cardiomyopathy. 2017/06
8.	Original article	High prevalence of cardiovascular risk factors in children and adolescents with Williams-Beuren syndrome. 2015/09
9.	Original article	Therapeutic Efficacy of Valproic Acid in a Combined Monocrotaline and Chronic Hypoxia Rat Model of Severe Pulmonary Hypertension. 2015/01
10.	Original article	Mutations of NOTCH3 in childhood pulmonary arterial hypertension. 2014/05
11.	Original article	Soluble ST2 and N-terminal pro-brain natriuretic peptide combination-Useful biomarker for predicting outcome of childhoodpulmonary arterial hypertension- 2014/02
12.	Original article	Prospective in vitro models of channelopathies and cardiomyopathies 2012
Display 5 items
Display all(12)

■ Academic conference presentation

1.	Contractile measurement of human bioengineered cardiac tissue using iPS cells derived from dilated cardiomyopathy patients with lamin variant. 2020/07/30
2.	iPS cell-derived cardiac tissue from dilated cardiomyopathy patients with lamin variant showed impaired systolic function. 2019/11/17
3.	Contractile measurement of human bioengineered cardiac tissue using iPS cells derived from dilated cardiomyopathy patients with lamin variant. 2019/11/14
4.	Contractile measurement of human bioengineered cardiac tissue using iPS cells derived from dilated cardiomyopathy patients with lamin variant. 2019/09/07
5.	Maternal and fetal outcomes in pregnant woman with surgically repaired congenital heart disease: retrospective Japanese multi-center study 2019/06/28
6.	Functional evaluation of human bioengineered cardiac tissue using iPS cells derived from dilated cardiomyopathy patients with lamin variant. 2019/06/04
7.	Clinical Outcomes of Mutation Carriers in Pulmonary Arterial Hypertension in Children 2012/11/07
8.	Double Gene Mutations in Long QT Syndrome Can Cause Significantly Increased Cardiac Event During Childhood 2012/11/04
9.	Long-Term Survival and Quality of Life of Patients with Chromosome 22q11.2 Deletion Syndrome:A Multi-Center Study 2011/11/13
Display 5 items
Display all(9)

■ Education

2002/11
Degree Acquisition

Tokyo Women's Medical University,

■ Rsearch funding number

10424673